With the clinical third phase to be carried out in more than 10 countries around the world, Seltrion will further verify the efficacy

With the clinical third phase to be carried 강남텐프로 out in more than 10 countries around the world, Seltrion will further verify the efficacy and safety of CT-P59 confirmed in phase II through a wider range of patients. It is also planning to produce up to 1.5 million to 2 million doses of treatments per year for mass supply to foreign countries. 강남텐카페 Chairman Seo Jung-jin said, "Development of medicine does not mean that we have a will for science," and added, "It will take time to analyze it, but we believe that we have reached the level of necessary conditions that can be scientifically proven." He added, "Corna 19 treatment (multinational pharmaceutical company) is currently expensive at around 4 million won, 강남가라오케 but the company will sell it at a reasonable price to prevent the word excessive."